Literature DB >> 3058803

Fc region-dependence of IgG3 anti-streptococcal group A carbohydrate antibody functional affinity. I. The effect of temperature.

N S Greenspan1, D A Dacek, L J Cooper.   

Abstract

Previous studies have demonstrated that IgG3 anti-streptococcal group A carbohydrate (GAC) mAb bind to the surfaces of heat-killed, pepsin-digested group A streptococcal cells in an Fc region-dependent cooperative manner. This form of positive cooperative binding of antibody to Ag was hypothesized to result from noncovalent association of Fc regions of antibodies bound close to one another on the Ag surface. Because IgG3 Fc regions are self-aggregating and IgG3 molecules are frequently cryoprecipitable, we have now investigated the effect of temperature on the binding, and cooperative binding, of IgG3 anti-GAC mAb to solid-phase (sp) Ag. The Ag used was a covalent conjugate of N-acetyl-D-glucosamine (GlcNAc; the epitopes on GAC) and BSA. The main findings were: 1) IgG3 anti-GAC mAb bind to sp GlcNAc-BSA to greater extents at lower temperatures, 2) IgM anti-GAC mAb and Fab and F(ab')2 fragments, derived from an IgG3 anti-GAC mAb, bind to sp GlcNAc-BSA to comparable extents at different temperatures, 3) idiotope-expressing IgG3 anti-GAC mAb bind to sp anti-idiotope to comparable extents at different temperatures, and 4) unlabeled IgG3 anti-GAC mAb enhance the binding of radiolabeled IgG3 anti-GAC mAb to sp GlcNAc-BSA, and the degree of this enhancement is greater at lower temperature. These, and additional results, support the conclusion that for some sp Ag the functional affinities of IgG3 antibodies, are influenced by the Fc region in a temperature-dependent manner.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3058803

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Groove-type recognition of chlamydiaceae-specific lipopolysaccharide antigen by a family of antibodies possessing an unusual variable heavy chain N-linked glycan.

Authors:  Omid Haji-Ghassemi; Sven Müller-Loennies; Radka Saldova; Mohankumar Muniyappa; Lore Brade; Pauline M Rudd; David J Harvey; Paul Kosma; Helmut Brade; Stephen V Evans
Journal:  J Biol Chem       Date:  2014-03-28       Impact factor: 5.157

2.  Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice.

Authors:  R R Yuan; G Spira; J Oh; M Paizi; A Casadevall; M D Scharff
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

3.  Cytologic assessment of nuclear and cytoplasmic O-linked N-acetylglucosamine distribution by using anti-streptococcal monoclonal antibodies.

Authors:  J R Turner; A M Tartakoff; N S Greenspan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 4.  Cooperative binding by mouse IgG3 antibodies: implications for functional affinity, effector function, and isotype restriction.

Authors:  N S Greenspan; L J Cooper
Journal:  Springer Semin Immunopathol       Date:  1993

5.  T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice.

Authors:  R R Yuan; A Casadevall; J Oh; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

6.  Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans.

Authors:  S L Zebedee; R K Koduri; J Mukherjee; S Mukherjee; S Lee; D F Sauer; M D Scharff; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

7.  Protective murine monoclonal antibodies to Cryptococcus neoformans.

Authors:  J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  Mapping effector functions of a monoclonal antibody to GD3 by characterization of a mouse-human chimeric antibody.

Authors:  P B Chapman; S D Gillies; A N Houghton; R M Reilly
Journal:  Cancer Immunol Immunother       Date:  1994-09       Impact factor: 6.968

9.  IgG3 deficiency extends lifespan and attenuates progression of glomerulonephritis in MRL/lpr mice.

Authors:  Neil S Greenspan; Myro A Lu; Jacob W Shipley; Xuedong Ding; Qing Li; Dilara Sultana; Maria Kollaros; John R Schreiber; Pingfu Fu; Chaim Putterman; Steven N Emancipator
Journal:  Biol Direct       Date:  2012-01-16       Impact factor: 4.540

10.  The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies.

Authors:  A Casadevall; M D Scharff
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.